Results 181 to 190 of about 55,959 (291)

Analysis of the QT interval prolongation and pharmaceuticals in elderly patients in ambulatory care [PDF]

, 2017
Nereida Ferraz Vieira do Prado, Ana Elize Turini, Giuliana Tonani Bollis, Fernanda Linhares, Alessandra Tieppo, Lívia Terezinha Devens, Renato Lírio Morelato, Alessandra Tieppo, Lívia Terezinha Devens, Renato Lírio Morelato   +9 more
openalex   +1 more source

Domperidone-Associated QT Interval Prolongation in Non-oncologic Pediatric Patients: A Review of the Literature.

The Canadian Journal of Hospital Pharmacy, 2016
A. Morris, Jennifer Chen, Elaine Lau, J. Poh   +3 more
semanticscholar   +1 more source

Donepezil‐Induced Severe Anorexia and T‐Wave Inversion in Early‐Onset Alzheimer's Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Donepezil hydrochloride, used to treat Alzheimer's disease, is typically initiated at a low dose and titrated to minimize gastrointestinal side effects. Despite its favorable safety profile, the patient developed severe anorexia, dehydration, and electrocardiographic abnormalities.
Nobuyuki Takahashi, Takeshi Kuroda, Takashi Yoshioka, Hidetomo Murakami, Hironori Tanaka   +4 more
wiley   +1 more source

QT interval prolongation in schizophrenia: A cross-sectional study from a tertiary care center in Raipur. [PDF]

Indian J Med Res
Malani M, Das S, Saha A, Kumar A, Singh S, Somani A.   +5 more
europepmc   +1 more source

Corrected QT interval prolongation after ganglionated plexus ablation: myth or reality?-Authors' reply. [PDF]

Europace, 2021
Hermans BJM, Zink MD, Rosmalen FV, Crijns HJGM, Vernooy K, Postema P, Pison L, Schotten U, Delhaas T.   +8 more
europepmc   +1 more source

Efavirenz Inhibits the Human Ether‐A‐Go‐Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers

Cardiovascular Electrophysiology, 2016
A. Abdelhady, Tyler Shugg, N. Thong, J. Lu, Y. Kreutz, H. Jaynes, J. Robarge, J. Tisdale, Z. Desta, B. Overholser   +9 more
semanticscholar   +1 more source

Concentration–QTc Modeling to Support Clinical Development of Fezolinetant

Clinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Fezolinetant is a non‐hormonal, selective neurokinin‐3 receptor antagonist that blocks neurokinin B activation of kisspeptin/neurokinin B/dynorphin neurons to thereby modulate neuronal activity in the thermoregulatory center. Fezolinetant has been approved in many regions, including North America, Europe, Asia, and Australia for the treatment ...
Jace C. Nielsen, Masako Saito, Xuegong Wang, Megumi Iwai, Graeme L. Fraser, Steven Ramael, Jiayin Huang   +6 more
wiley   +1 more source

QT-Interval Prolongation and 1-Year Cardiac Death Among Patients Undergoing Hemodialysis. [PDF]

JACC Asia
Sasaki S, Fujisaki K, Nishimura M, Nakano T, Abe M, Hanafusa N, Joki N.   +6 more
europepmc   +1 more source

Development and Validation of a Nomogram for Prediction of QT Interval Prolongation in Patients Administered Bedaquiline-Containing Regimens in China: a Modeling Study. [PDF]

Antimicrob Agents Chemother, 2022
Liu F, Gao J, Gao M, Liu Y, Shu W, Xie L, Sun Y, Zhang L, Li L, Pang Y.   +9 more
europepmc   +1 more source

Electrocardiographic change: prolongation of the QT interval, imminent risk of sudden death [PDF]

Lígia Maria Oliveira de Souza
openalex   +1 more source